Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Financial Flexibility Index
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥697.36 Million (operating CF CN¥282.81 Million minus capex CN¥414.56 Million) represents 0% of total liabilities (CN¥11.55 Billion). Also explore 600521 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Huahai Pharmaceutical Co Ltd Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Check 600521 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Huahai Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600521 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥3.20 Billion | CN¥1.23 Billion | CN¥12.05 Billion | ▼ -25.9% |
| 2024 | 0.36x | CN¥4.03 Billion | CN¥2.17 Billion | CN¥11.24 Billion | ▼ -2.7% |
| 2023 | 0.37x | CN¥3.81 Billion | CN¥2.22 Billion | CN¥10.35 Billion | ▲ +7.6% |
| 2022 | 0.34x | CN¥3.56 Billion | CN¥1.24 Billion | CN¥10.41 Billion | ▼ -11.9% |
| 2021 | 0.39x | CN¥3.37 Billion | CN¥938.43 Million | CN¥8.69 Billion | ▼ -14.1% |
| 2020 | 0.45x | CN¥2.83 Billion | CN¥1.56 Billion | CN¥6.27 Billion | ▼ -12.2% |
| 2019 | 0.51x | CN¥2.55 Billion | CN¥1.75 Billion | CN¥4.95 Billion | ▲ +165.9% |
| 2018 | 0.19x | CN¥1.19 Billion | CN¥67.90 Million | CN¥6.16 Billion | ▼ -53.6% |
| 2017 | 0.42x | CN¥1.34 Billion | CN¥546.24 Million | CN¥3.21 Billion | ▼ -23.1% |
| 2016 | 0.54x | CN¥1.17 Billion | CN¥433.10 Million | CN¥2.15 Billion | ▲ +35.4% |
| 2015 | 0.40x | CN¥719.59 Million | CN¥195.31 Million | CN¥1.80 Billion | ▼ -34.9% |
| 2014 | 0.62x | CN¥765.67 Million | CN¥328.61 Million | CN¥1.24 Billion | ▼ -6.9% |
| 2013 | 0.66x | CN¥956.53 Million | CN¥490.29 Million | CN¥1.45 Billion | ▲ +21.2% |
| 2012 | 0.55x | CN¥691.64 Million | CN¥243.83 Million | CN¥1.27 Billion | ▲ +5.1% |
| 2011 | 0.52x | CN¥543.58 Million | CN¥197.51 Million | CN¥1.05 Billion | ▼ -33.2% |
| 2010 | 0.78x | CN¥571.91 Million | CN¥299.47 Million | CN¥735.92 Million | ▼ -9.3% |
| 2009 | 0.86x | CN¥448.25 Million | CN¥317.44 Million | CN¥522.98 Million | ▲ +59.2% |
| 2008 | 0.54x | CN¥223.10 Million | CN¥84.20 Million | CN¥414.51 Million | ▼ -39.7% |
| 2007 | 0.89x | CN¥257.07 Million | CN¥136.52 Million | CN¥287.78 Million | ▼ -7.8% |
| 2006 | 0.97x | CN¥215.81 Million | CN¥77.54 Million | CN¥222.66 Million | ▼ -44.7% |
| 2005 | 1.75x | CN¥302.44 Million | CN¥53.30 Million | CN¥172.70 Million | ▼ -32.0% |
| 2004 | 2.57x | CN¥283.20 Million | CN¥163.73 Million | CN¥110.03 Million | ▲ +143.0% |
| 2003 | 1.06x | CN¥94.54 Million | CN¥47.41 Million | CN¥89.27 Million | ▲ +43.2% |
| 2002 | 0.74x | CN¥123.93 Million | CN¥75.34 Million | CN¥167.62 Million | ▲ +52.3% |
| 2001 | 0.49x | CN¥73.65 Million | CN¥37.51 Million | CN¥151.72 Million | — |